Adjuvant Gemcitabine-cisplatin Combination for Biliary Tract Cancer: A Real Life Experience

Adjuvant Gemcitabine-cisplatin Combination for Biliary Tract Cancer: A Real Life Experience

Aim: Biliary tract cancers (BTCs), including gallbladder and cholangiocarcinomas, are aggressive malignancies with poor long-term survival despite surgical resection. The efficacy of adjuvant therapy in BTCs remains controversial, particularly in the absence of consistent phase 3 data supporting its...

Full description

Saved in:
Bibliographic Details
Main Authors: Fatih Kuş, Hasan Çağrı Yıldırım, Arif Akyıldız, Ömer Denizhan Tatar, Alperen Özmen, Fırat Şirvan, Fatih Boynueğrioğlu, Barış Köksal, Deniz Can Güven, Ömer Dizdar, Şuayib Yalçın
Format: Article
Language:English
Published: Galenos Publishing House 2025-08-01
Series:Acta Haematologica Oncologica Turcica
Subjects:
biliary tract cancer
adjuvant chemotherapy
gemcitabine-cisplatin combination
capecitabine
cholangiocarcinoma
Online Access:https://www.actaoncologicaturcica.com/articles/adjuvant-gemcitabine-cisplatin-combination-for-biliary-tract-cancer-a-real-life-experience/doi/ahot.galenos.2025.2025-6-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.actaoncologicaturcica.com/articles/adjuvant-gemcitabine-cisplatin-combination-for-biliary-tract-cancer-a-real-life-experience/doi/ahot.galenos.2025.2025-6-2

Similar Items